Real-time Prediction of COVID-19 related Mortality using Electronic Health Records

• URL: http://arxiv.org/abs/2008.13412v1
• Date: Mon, 31 Aug 2020 08:07:27 GMT
• Title: Real-time Prediction of COVID-19 related Mortality using Electronic Health Records
• Authors: Patrick Schwab, Arash Mehrjou, Sonali Parbhoo, Leo Anthony Celi, J\"urgen Hetzel, Markus Hofer, Bernhard Sch\"olkopf, Stefan Bauer
• Abstract summary: COVID-19 Early Warning System (CovEWS) is a clinical risk scoring system for assessing COVID-19 related mortality risk. CovEWS provides continuous real-time risk scores for individual patients with clinically meaningful predictive performance up to 192 hours (8 days) in advance.
• Score: 30.892335739985526
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Coronavirus Disease 2019 (COVID-19) is an emerging respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with rapid human-to-human transmission and a high case fatality rate particularly in older patients. Due to the exponential growth of infections, many healthcare systems across the world are under pressure to care for increasing amounts of at-risk patients. Given the high number of infected patients, identifying patients with the highest mortality risk early is critical to enable effective intervention and optimal prioritisation of care. Here, we present the COVID-19 Early Warning System (CovEWS), a clinical risk scoring system for assessing COVID-19 related mortality risk. CovEWS provides continuous real-time risk scores for individual patients with clinically meaningful predictive performance up to 192 hours (8 days) in advance, and is automatically derived from patients' electronic health records (EHRs) using machine learning. We trained and evaluated CovEWS using de-identified data from a cohort of 66430 COVID-19 positive patients seen at over 69 healthcare institutions in the United States (US), Australia, Malaysia and India amounting to an aggregated total of over 2863 years of patient observation time. On an external test cohort of 5005 patients, CovEWS predicts COVID-19 related mortality from $78.8\%$ ($95\%$ confidence interval [CI]: $76.0$, $84.7\%$) to $69.4\%$ ($95\%$ CI: $57.6, 75.2\%$) specificity at a sensitivity greater than $95\%$ between respectively 1 and 192 hours prior to observed mortality events - significantly outperforming existing generic and COVID-19 specific clinical risk scores. CovEWS could enable clinicians to intervene at an earlier stage, and may therefore help in preventing or mitigating COVID-19 related mortality.

Related papers

• At-Admission Prediction of Mortality and Pulmonary Embolism in COVID-19 Patients Using Statistical and Machine Learning Methods: An International Cohort Study [0.0]
  It is highly important to develop predictive tools for pulmonary embolism in COVID-19 patients. We propose a cost-sensitive gradient-boosted machine learning model that predicts occurrence of PE and death at admission.
  arXiv  Detail & Related papers  (2023-05-18T14:55:27Z)
• COVID-Net CXR-S: Deep Convolutional Neural Network for Severity Assessment of COVID-19 Cases from Chest X-ray Images [74.77272804752306]
  We introduce COVID-Net CXR-S, a convolutional neural network for predicting the airspace severity of a SARS-CoV-2 positive patient based on a CXR image of the patient's chest. We leveraged transfer learning to transfer representational knowledge gained from over 16,000 CXR images from a multinational cohort of over 15,000 patient cases into a custom network architecture for severity assessment. The proposed COVID-Net CXR-S has potential to be a powerful tool for computer-aided severity assessment of CXR images of COVID-19 positive patients.
  arXiv  Detail & Related papers  (2021-05-01T14:15:12Z)
• Machine learning approach to dynamic risk modeling of mortality in COVID-19: a UK Biobank study [0.0]
  The COVID-19 pandemic has created an urgent need for robust, scalable monitoring tools supporting stratification of high-risk patients. This research aims to develop and validate prediction models, using the UK Biobank, to estimate COVID-19 mortality risk in confirmed cases.
  arXiv  Detail & Related papers  (2021-04-19T11:51:20Z)
• COVIDx-US -- An open-access benchmark dataset of ultrasound imaging data for AI-driven COVID-19 analytics [116.6248556979572]
  COVIDx-US is an open-access benchmark dataset of COVID-19 related ultrasound imaging data. It consists of 93 lung ultrasound videos and 10,774 processed images of patients infected with SARS-CoV-2 pneumonia, non-SARS-CoV-2 pneumonia, as well as healthy control cases.
  arXiv  Detail & Related papers  (2021-03-18T03:31:33Z)
• Machine Learning and Meta-Analysis Approach to Identify Patient Comorbidities and Symptoms that Increased Risk of Mortality in COVID-19 [1.221966660783828]
  Many individuals who become infected have pre-existing conditions that may interact with COVID-19 to increase symptom severity and mortality risk. We performed a meta-analysis of the published global literature, and machine learning predictive analysis using an aggregated COVID-19 global dataset. Results: Our meta-analysis identified chronic obstructive pulmonary disease (COPD), cerebrovascular disease (CEVD), cardiovascular disease (CVD), type 2 diabetes, malignancy, and hypertension as most significantly associated with COVID-19 severity.
  arXiv  Detail & Related papers  (2020-08-21T12:31:54Z)
• An early warning tool for predicting mortality risk of COVID-19 patients using machine learning [0.0]
  A retrospective study was conducted on 375 COVID-19 positive patients admitted to Tongji Hospital (China) from January 10 to February 18, 2020. A nomogram was developed for predicting the mortality risk among COVID-19 patients. An integrated score (LNLCA) was calculated with the corresponding death probability.
  arXiv  Detail & Related papers  (2020-07-29T15:16:09Z)
• Integrative Analysis for COVID-19 Patient Outcome Prediction [53.11258640541513]
  We combine radiomics of lung opacities and non-imaging features from demographic data, vital signs, and laboratory findings to predict need for intensive care unit admission. Our methods may also be applied to other lung diseases including but not limited to community acquired pneumonia.
  arXiv  Detail & Related papers  (2020-07-20T19:08:50Z)
• Remote health monitoring and diagnosis in the time of COVID-19 [51.01158603315544]
  Coronavirus disease (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pandemic has driven incentives to innovate and enhance or create new routes for providing healthcare services at distance.
  arXiv  Detail & Related papers  (2020-05-18T08:54:38Z)
• Clinical Predictive Models for COVID-19: Systematic Study [23.62256555920893]
  Coronavirus Disease 2019 (COVID-19) is a rapidly emerging respiratory disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Due to the rapid human-to-human transmission of SARS-CoV-2, many healthcare systems are at risk of exceeding their healthcare capacities. Predictive algorithms could potentially ease the strain by identifying those who are most likely to receive a positive SARS-CoV-2 test, be hospitalised or admitted to the ICU.
  arXiv  Detail & Related papers  (2020-05-17T17:10:39Z)
• Dual-Sampling Attention Network for Diagnosis of COVID-19 from Community Acquired Pneumonia [46.521323145636906]
  We develop a dual-sampling attention network to automatically diagnose COVID-19 from the community acquired pneumonia (CAP) in chest computed tomography (CT) In particular, we propose a novel online attention module with a 3D convolutional network (CNN) to focus on the infection regions in lungs when making decisions of diagnoses. Our algorithm can identify the COVID-19 images with the area under the receiver operating characteristic curve (AUC) value of 0.944, accuracy of 87.5%, sensitivity of 86.9%, specificity of 90.1%, and F1-score of 82.0%.
  arXiv  Detail & Related papers  (2020-05-06T09:56:51Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.